Ellis Andrea sold BBIO
August 5, 2025 · Form 4 insider transaction
Ellis Andrea sold 17,167 shares of BridgeBio Pharma, Inc. at $49.00 per share, a transaction worth $841.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
17,167
Price
$49.00
Total value
$841.2K
InsiderEllis Andrea
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 5, 2025
Filing dateAugust 7, 2025
Shares owned after18,589
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024.